FIG 3.

Changes in FEV₁% predicted by primary microbiologic endpoint (A) and by secondary microbiologic outcome at year 5 (B). See Table 2 for a description of microbiologic outcomes. (A) Mean annualized FEV₁% predicted by primary microbiologic endpoint at each reporting year. CI, confidence interval. (B) Mean annualized FEV₁% predicted across the study for subjects who met or did not meet the secondary microbiologic outcome at reporting year 5. Note that subjects could move between AZLI use categories (yes/no for each year) across the study. SE, standard error.